Method of treating HBV infection by using anti-pre-S1 HBV antibodies
AssigneeHuahui Health Ltd.
InventorsWenhui Li, Jianhua Sui, Pan Chen
Life of this patent
Estimating the term…
Abstract
A method for treating HBV infection in a subject, comprising administering to the subject an anti-pre-S1 antibody or a fragment thereof at a dose of about 0.1 mg/kg to about 80 mg/kg. Also relates to an anti-pre-S1 antibody or a fragment thereof for use in treating HBV infection.
Claims9
A method for treating HBV infection in a subject, comprising administering to the subject an effective amount of HH-003, wherein the HH-003 is administered at a dose of 3 mg/kg to 40 mg/kg, wherein the subject is human, wherein the HBV infection is chronic HBV infection, wherein HH-003 is an anti-pre-S1 antibody, wherein HH-003 comprises a heavy chain having the amino acid sequence of SEQ ID NO:
- 9 and a light chain having the amino acid sequence of SEQ ID NO:
- 10.
Dependencies are inferred from the claim text.